Letrozole and Gad - a phase IV clinical study of FDA data

Summary:

Gad is reported as a side effect among people who take Letrozole (letrozole), especially for people who are female, 60+ old, have been taking the drug for 2 - 5 years also take Kisqali, and have High blood pressure.

The phase IV clinical study analyzes which people have Gad when taking Letrozole. It is created by eHealthMe based on reports of 53,470 people who have side effects when taking Letrozole from the FDA, and is updated regularly.

What is Letrozole?

Letrozole has active ingredients of letrozole. It is often used in breast cancer. eHealthMe is studying from 54,122 Letrozole users. Check the latest studies of Letrozole.

What is Gad?

Gad is found to be associated with 859 drugs and 1,472 conditions by eHealthMe. Check the latest studies of Gad.

On Oct, 09, 2025

53,470 people reported to have side effects when taking Letrozole.
Among them, 21 people (0.04%) have Gad.

Among these 21 people:

How long have people been on Letrozole when they have Gad? *

What is the gender of people who have Gad when taking Letrozole? *

female: 100 %
male: 0.0 %

What is the age of people who have Gad when taking Letrozole? *

What are other drugs people take besides Letrozole? *

What are other side effects people have besides Gad? *

Dyspnea (difficult or laboured breathing): 11 people, 52.38%
Fatigue (feeling of tiredness): 8 people, 38.10%
Weight Decreased: 8 people, 38.10%
Joint Pain: 7 people, 33.33%
Nausea (feeling of having an urge to vomit): 6 people, 28.57%
White Blood Cell Count Decreased: 6 people, 28.57%
Nasopharyngitis (inflammation of the nasopharynx): 5 people, 23.81%
Panic Disorder: 4 people, 19.05%
Malignant Neoplasm Of Pleura (cancer tumour of lung covering): 4 people, 19.05%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 4 people, 19.05%

What are the existing conditions these people have? *

High Blood Pressure: 4 people, 19.05%
Radiation Pneumonitis (inflammation of lung due to radiation): 2 people, 9.52%
Breast Cancer Female: 2 people, 9.52%
Metastases To Bone (cancer spreads to bone): 1 person, 4.76%
Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 1 person, 4.76%

* Approximation only. Some reports may have incomplete information.

Do you take Letrozole and have Gad?

- Check whether Gad is associated with a drug or a condition (FREE)
- Predict drug outcomes for up to one year with AI (FREE)
- Get an AI agent to monitor your drugs continuously (FREE)

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Letrozole:

Letrozole (54,122 reports)

Gad treatments and more:

Gad (31,241 reports)

Browse all side effects of Letrozole:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Gad:

Gad (859 drugs)

Browse all the conditions that are associated with Gad:

Gad (1,472 conditions)

Drugs similar to Letrozole and Gad :

How the study uses the data?

The study uses data from the FDA. It is based on letrozole (the active ingredients of Letrozole) and Letrozole (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.